Northpond Ventures GP, LLC - 14 Sep 2021 Form 3 Insider Report for DICE Therapeutics, Inc.

Role
10%+ Owner
Signature
Northpond Ventures GP, LLC By: /s/ Patrick Smerkers, Senior Vice President, Finance and Operations
Issuer symbol
N/A
Transactions as of
14 Sep 2021
Net transactions value
$0
Form type
3
Filing time
14 Sep 2021, 21:25:05 UTC
Previous filing
24 Jun 2021
Next filing
20 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DICE Series B Convertible Preferred Stock 14 Sep 2021 Common Stock 1,735,388 By: Northpond Ventures, LP F1, F4
holding DICE Series C Convertible Preferred Stock 14 Sep 2021 Common Stock 867,687 By: Northpond Ventures, LP F2, F4
holding DICE Series C-1 Convertible Preferred Stock 14 Sep 2021 Common Stock 454,796 By: Northpond Ventures II, LP F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Convertible Preferred Stock"), of DICE Therapeutics, Inc. (the "Issuer") will automatically convert on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock") prior to the closing of the Issuer's initial public offering of its Common Stock. The Series B Convertible Preferred Stock has no expiration date.
F2 All shares of Series C Convertible Preferred Stock, par value $0.0001 per share (the "Series C Convertible Preferred Stock"), of the "Issuer will automatically convert on a one-for-one basis into shares of the Issuer's Common Stock prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Preferred Stock has no expiration date.
F3 All shares of Series C-1 Convertible Preferred Stock, par value $0.0001 per share (the "Series C-1 Convertible Preferred Stock"), of the "Issuer will automatically convert on a one-for-one basis into shares of the Issuer's Common Stock prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C-1 Preferred Stock has no expiration date.
F4 Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F5 Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.